Predicted Commercialization of Numerous Drugs to Arrest Antibacterial Drugs Market Slide

Antibacterial drugs were first formulated in 1928 and have been used ever since. Antibacterial drugs are defined as substances that can inhibit or destroy the development and growth of bacteria. They are often called as antibiotics and are broadly utilized in the treatment and prevention of infectious diseases. A broad range of antibacterial drugs are available in the market which can be utilized in treating diseases such as tetanus, diarrhea, pneumonia, tuberculosis, and various other diseases.

Browse Full Report Global Antibacterial Drugs Market Research Report With Full TOC @ http://www.transparencymarketresearch.com/antibacterial-drugs-market.html

The global antibacterial drugs market will decline at a -1.3% CAGR between 2015 and 2023. The market stood at US$43.9 billion in 2014 and is predicted to reach US$38.8 billion by 2023.

Antibacterial Drugs Market to Decline despite the Presence of Numerous Manufacturers

An increase in the number of generic drugs used in antibacterial treatment, reduced R&D, patent expiry, and rising market stagnancy are amongst the factors impeding the growth of the antibacterial drugs market.

However, a rising demand for affordable and effective antibacterial drugs, rise in aging population, presence of a large number of manufacturers in the market, and rising occurrence of infectious diseases are some of the factors fuelling the demand for antibacterial drugs. To add on, the predicted commercialization of numerous drugs that are at present in the development stage, namely VivaGel (SPL7013) (Starpharma Holdings Limited), solithromycin (Cempra, Inc.), MK-3415A (Merck & Co.), and surotomycin (Merck & Co.), could help counteract the negative market forces discussed above.

Β-Lactams Dominated the Market in 2014 with a Share of 57.7%

On the basis of class, the global antibacterial drugs market has been segmented into tetracyclines, macrolides, aminoglycosides, sulfonamides, β-lactams, phenicols, and miscellaneous...